Thomas J. Herzfeld Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-18
| Closed | -$2.73K | – | 170 |
|
|
2024
Q2 | $2.73K | Buy |
+18
| New | +$2.71K | ﹤0.01% | 182 |
|
|
2023
Q4 | – | Sell |
-83
| Closed | -$11.2K | – | 174 |
|
|
2023
Q3 | $11.2K | Hold |
83
| – | – | ﹤0.01% | 174 |
|
|
2023
Q2 | $11.9K | Sell |
83
-13
| -14% | -$1.91K | ﹤0.01% | 170 |
|
|
2023
Q1 | $13.3K | Hold |
96
| – | – | 0.01% | 143 |
|
|
2022
Q4 | $13K | Buy |
96
+28
| +41% | +$3.51K | 0.01% | 147 |
|
|
2022
Q3 | $7K | Hold |
68
| – | – | ﹤0.01% | 172 |
|
|
2022
Q2 | $9K | Hold |
68
| – | – | ﹤0.01% | 168 |
|
|
2022
Q1 | $9K | Hold |
68
| – | – | ﹤0.01% | 184 |
|
|
2021
Q4 | $8K | Hold |
68
| – | – | ﹤0.01% | 223 |
|
|
2021
Q3 | $8K | Hold |
68
| – | – | ﹤0.01% | 211 |
|
|
2021
Q2 | $8K | Buy |
68
+18
| +36% | +$1.98K | ﹤0.01% | 222 |
|
|
2021
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 247 |
|
|
2020
Q4 | $5K | Buy |
50
+11
| +28% | +$1.17K | ﹤0.01% | 234 |
|
|
2020
Q3 | $4K | Hold |
39
| – | – | ﹤0.01% | 198 |
|
|
2020
Q2 | $4K | Buy |
+39
| New | +$4.03K | ﹤0.01% | 229 |
|
|
2017
Q3 | – | Sell |
-176
| Closed | -$12K | – | 290 |
|
|
2017
Q2 | $12K | Sell |
176
-117
| -40% | -$7.64K | 0.01% | 231 |
|
|
2017
Q1 | $18K | Sell |
293
-96
| -25% | -$5.59K | 0.01% | 273 |
|
|
2016
Q4 | $21K | Buy |
389
+44
| +13% | +$2.5K | 0.01% | 276 |
|
|
2016
Q3 | $23K | Sell |
345
-590
| -63% | -$38.6K | 0.01% | 255 |
|
|
2016
Q2 | $56K | Buy |
935
+55
| +6% | +$3.19K | 0.03% | 187 |
|
|
2016
Q1 | $50K | Sell |
880
-107
| -11% | -$6.43K | 0.03% | 199 |
|
|
2015
Q4 | $67K | Hold |
987
| – | – | 0.03% | 189 |
|
|
2015
Q3 | $63K | Buy |
987
+100
| +11% | +$6.58K | 0.03% | 180 |
|
|
2015
Q2 | $28K | Buy |
+887
| New | +$60.7K | 0.01% | 222 |
|
Other funds holding AZN
